LillyDirect vs NovoCare vs Telehealth: Which Channel Should You Use?
Three ways to buy a GLP-1 without insurance, compared: LillyDirect's dose-tiered vial pricing, NovoCare's flat pricing across strengths, and bundled telehealth — with worked cost examples by dose.
Affiliate & Medical Disclosure
This article may contain affiliate links and sponsored content. Product recommendations may be influenced by affiliate commissions. This content is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making medical decisions.Read full disclaimer
There are now three distinct ways to buy a GLP-1 in the United States without insurance: directly from Eli Lilly through LillyDirect, directly from Novo Nordisk through NovoCare® Pharmacy, or through a telehealth platform that bundles care with medication. They differ in price, in what you receive, and in what you have to arrange yourself. This comparison sets out how each channel works and which one fits which patient.
Quick Takeaway:
- LillyDirect sells Lilly products (Zepbound, Mounjaro, oral Foundayo) at published dose-tiered self-pay prices of $349–$699
- NovoCare® Pharmacy sells Novo products (Wegovy, Ozempic), launching Wegovy at $499/month flat across all dose strengths
- Neither manufacturer channel includes clinical care, coaching, or titration management — you must arrange a prescriber
- Bundled telehealth programmes include care and medication together, typically $179–$400 all in, but usually with compounded product
- Major telehealth platforms now route branded prescriptions through the manufacturer channels
Looking for a Better Alternative?
For patients who want care and medication handled together in one price, CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy, combining competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.
Why we recommend CoreAge Rx:
- Lower monthly costs than most competitors ($179–$399 range)
- Faster prescription approval (typically 12–24 hours)
- More extensive provider support included at no extra charge
- Better medication availability during shortages
- Higher patient satisfaction scores (4.7/5)
New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. No insurance required.
The Three Channels Compared
| LillyDirect | NovoCare® Pharmacy | Bundled telehealth | |
|---|---|---|---|
| Products | Zepbound, Mounjaro, Foundayo | Wegovy, Ozempic | Compounded semaglutide/tirzepatide |
| Molecule | Tirzepatide, orforglipron | Semaglutide | Both, compounded |
| FDA-approved | Yes | Yes | No — compounded |
| Published pricing | $349–$699 by dose | $499 flat at launch; $349 reported DTC | ~$179–$400 all in |
| Dose pricing | Tiered — rises with dose | Flat across strengths at launch | Usually tiered |
| Clinical care included | No | No | Yes |
| Coaching / titration support | No | No | Usually yes |
| Prescriber required | Yes, sourced separately | Yes, sourced separately | Provided |
| Subscription | None | None | Usually monthly |
LillyDirect in Detail
LillyDirect is Eli Lilly's direct-to-patient pharmacy and prescriber referral channel. Published Zepbound single-dose vial self-pay pricing has been $349 for 2.5 mg, $499 for 5 mg and for 7.5 mg on initial fill and refills within 45 days, $599 for 7.5 mg refills after 45 days, and $699 for 10 mg.
Lilly has also used the channel to launch its oral GLP-1, Foundayo (orforglipron), directly to consumers as well as through Amazon Pharmacy, telehealth providers, and pharmacies. A Medicare GLP-1 Bridge programme operates with specific clinical criteria that must all apply at treatment start.
The dose-tier issue. LillyDirect's pricing roughly doubles between 2.5 mg and 10 mg. Since most patients titrate upward over several months, your cost rises as your dose does. The 45-day refill rule on 7.5 mg is a further $100/month trap for anyone who lets a fill lapse.
Read the full LillyDirect review.
NovoCare® Pharmacy in Detail
NovoCare® is Novo Nordisk's patient support platform, with NovoCare® Pharmacy as its direct-dispensing arm. Wegovy launched on the channel at $499 per month cash for all dose strengths — a flat structure — with subsequent reporting describing a $349 per month direct-to-consumer self-pay price for both Wegovy and Ozempic against list prices of roughly $1,349 and $998.
Patients can have medication shipped directly, or take a savings offer to a retail pharmacy for collection.
The flat pricing advantage. Because the launch price applied across all dose strengths, escalating to a maintenance dose carried no additional cost. For a patient expecting to need a high dose, that is a structural advantage over tiered vial pricing — potentially several hundred dollars a month.
Read the full NovoCare Pharmacy review.
The Telehealth Channel in Detail
Bundled telehealth programmes include the prescriber, the medication, titration management, and messaging in one monthly price — typically $179–$400. The medication is usually a compounded preparation rather than FDA-approved product.
Separately, a growing number of telehealth platforms now act as a front end to the manufacturer channels rather than competing with them. Hims & Hers routes Lilly prescriptions to LillyDirect; Lemonaid offers Zepbound vials through LillyDirect; Ro has publicised a NovoCare integration allowing Wegovy ordering inside its app; Novo Nordisk expanded GLP-1 access through Hims & Hers, LifeMD, and Ro via a NovoCare collaboration.
Important: When a telehealth platform routes you to a manufacturer channel, you pay the platform's membership fee and the manufacturer's medication price. That is legitimate — you are buying coordination — but it means the platform is not reducing your drug cost. It is adding a fee on top of a price you could pay directly.
Which Channel Fits Which Patient
Choose LillyDirect if: you have a prescriber already, you specifically want tirzepatide or the oral GLP-1, you are on a lower dose where pricing is most competitive, and you do not need care included.
Choose NovoCare if: you have a prescriber already, you want semaglutide, and particularly if you expect to need a high maintenance dose where flat pricing wins.
Choose bundled telehealth if: you have no prescriber, you want titration managed for you, you want the lowest all-in monthly cost, and you accept compounded rather than FDA-approved product.
Choose a low-cost care subscription plus a manufacturer channel if: you want FDA-approved product and clinical support. Sesame at $59/month or Lemonaid at $49/month plus manufacturer pricing is the cheapest way to combine both.
Choose none of these if: you have insurance coverage. A pharmacy benefit copay beats every channel here. See our insurance guide.
Cost Worked Through
Tirzepatide at a 10 mg maintenance dose:
| Route | Monthly total | Product type |
|---|---|---|
| Bundled telehealth programme | $179–$399 | Compounded |
| Sesame + LillyDirect | $59 + $699 = $758 | FDA-approved |
| LillyDirect alone | $699 | FDA-approved |
| Hims & Hers + LillyDirect | $149 + $699 = $848 | FDA-approved |
Semaglutide at a maintenance dose:
| Route | Monthly total | Product type |
|---|---|---|
| Bundled telehealth programme | $179–$349 | Compounded |
| NovoCare alone | $349–$499 | FDA-approved |
| Lemonaid + NovoCare | $49 + $349–$499 | FDA-approved |
| Ro Body + branded drug | ~$344–$598 | FDA-approved |
Frequently Asked Questions
What is the difference between LillyDirect and NovoCare?
They are the manufacturer-direct channels of two different companies. LillyDirect sells Eli Lilly products — Zepbound, Mounjaro, and the oral GLP-1 Foundayo — at dose-tiered prices of $349–$699. NovoCare® Pharmacy sells Novo Nordisk products — Wegovy and Ozempic — and launched Wegovy at $499 per month flat across all dose strengths.
Are manufacturer channels cheaper than telehealth?
For FDA-approved medication, yes — manufacturer self-pay pricing is below retail and below what telehealth platforms charge on top of it. But bundled compounded telehealth programmes at $179–$400 all in are cheaper still, because compounded preparations are not FDA-approved products.
Do LillyDirect or NovoCare provide a doctor?
Neither provides ongoing clinical care. Both can connect you with independent prescribers, but they do not employ those clinicians, manage your titration, or provide coaching. You need a prescriber relationship separately.
Why do telehealth platforms route to manufacturer pharmacies?
Because it lets them offer FDA-approved medication without operating their own supply chain. Hims & Hers routes Lilly prescriptions to LillyDirect, and Novo Nordisk has expanded access through Hims & Hers, LifeMD, and Ro via NovoCare. You pay the platform fee plus the manufacturer's medication price.
Which channel is best at high doses?
NovoCare's flat pricing across dose strengths is structurally advantageous at high doses. LillyDirect's tiered vial pricing reaches $699 at 10 mg, roughly double its 2.5 mg price.
Can I use insurance with these channels?
Manufacturer self-pay pricing is designed as an alternative to insurance, not a supplement. If your pharmacy benefit covers the medication, filling under your benefit will usually cost less than any of these routes.
Bottom Line
Three channels, three different propositions. Manufacturer-direct gives you FDA-approved medication at a fair published price and nothing else. Bundled telehealth gives you care and medication together at the lowest total cost, using compounded product. A low-cost care subscription plus a manufacturer channel splits the difference — approved medicine with clinical support for around $400–$760 a month.
Decide first whether FDA-approved product is a requirement for you. That answer determines your channel more than price does. Then, within that channel, price your specific dose — because at 2.5 mg and at 10 mg, the rankings change.
CoreAge Rx bundles medication, provider messaging, and titration support into one monthly price from $179–$399, with 12–24 hour approvals. Save up to $200 on your first three months.
Medical disclaimer: Informational only, not medical advice. GLP-1 receptor agonists are prescription medicines with real risks and contraindications. Compounded medications are not FDA-approved. Pricing changes frequently; verify directly with each channel.
Sources: LillyDirect and NovoCare® published self-pay pricing and programme pages; AJMC and Fierce Healthcare reporting on manufacturer–telehealth collaborations; Ro press release on the NovoCare integration; FDA prescribing information.
Date reviewed: August 2026
About the Author
Dr. Robert Janssen
Clinical Pharmacologist, Amsterdam Medical Center